Erratum for Marrero Rolon et al., “Clinical Evaluation of a Real-Time PCR Assay for Simultaneous Detection of
Helicobacter pylori
and Genotypic Markers of Clarithromycin Resistance Directly from Stool”
Journal of Clinical Microbiology | February 16, 2022 | Volume: 60 | Issue: 2 | Pages: No page available
Clinical Evaluation of a Real-Time PCR Assay for Simultaneous Detection of Helicobacter pylori and Genotypic Markers of Clarithromycin Resistance Directly from Stool
Journal of Clinical Microbiology | February 4, 2021 | Volume: 59 | Issue: 5 | Pages: No page available
Helicobacter pylori infection is mainly diagnosed noninvasively, with susceptibility testing traditionally requiring endoscopy. Treatment is empirical, with clarithromycin-based triple therapy recommended where resistance rates are below 15%. Rising rates of clarithromycin resistance, resulting in high therapy failure rates, are seen worldwide, but U.S. data are limited.